標(biāo)題: Titlebook: Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl; M. Azria,J. Engel,H. Sindermann Conf [打印本頁] 作者: 大破壞 時(shí)間: 2025-3-21 19:30
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl影響因子(影響力)
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl影響因子(影響力)學(xué)科排名
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl網(wǎng)絡(luò)公開度
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl被引頻次
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl被引頻次學(xué)科排名
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl年度引用
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl年度引用學(xué)科排名
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl讀者反饋
書目名稱Calcitonins — Physiological and Pharmacological Aspects. Mafosfamide — A Derivative of 4-Hydroxycycl讀者反饋學(xué)科排名
作者: 物種起源 時(shí)間: 2025-3-21 20:55 作者: 聲音刺耳 時(shí)間: 2025-3-22 03:08
,Mafosfamide — A Derivative of 4-Hydroxycyclophosphamide,of the anticancer drug cyclophosphamide (CP), involved a stereoselective synthesis and an optimized cation exchange with subsequent lyophilization. The stereochemical and physicochemical characterization of MA elucidated further the complex metabolic behavior of oxazaphosphorine cytostatics and conf作者: tattle 時(shí)間: 2025-3-22 07:48 作者: 打折 時(shí)間: 2025-3-22 10:02 作者: 直覺沒有 時(shí)間: 2025-3-22 13:57 作者: 直覺沒有 時(shí)間: 2025-3-22 20:24
Erlebnisinszenierung in den sozialen Medien,n the subject of numerous investigations especially during the last decade. This review is an attempt to summarize the present knowledge about synthesis, distribution and possible functions of 5-methylcytosine especially in eukaryotic genomes.作者: 調(diào)情 時(shí)間: 2025-3-22 22:37
https://doi.org/10.1007/978-3-642-74734-2Calcitonin; DNA; information; methylation; pharmacology作者: 人充滿活力 時(shí)間: 2025-3-23 03:51
978-3-642-74736-6Springer-Verlag Berlin Heidelberg 1989作者: 積云 時(shí)間: 2025-3-23 06:13
Enzymatic DNA Methylation,n the subject of numerous investigations especially during the last decade. This review is an attempt to summarize the present knowledge about synthesis, distribution and possible functions of 5-methylcytosine especially in eukaryotic genomes.作者: 野蠻 時(shí)間: 2025-3-23 10:42 作者: 支柱 時(shí)間: 2025-3-23 15:02 作者: 紅腫 時(shí)間: 2025-3-23 18:15
0177-8757 Overview: 978-3-642-74736-6978-3-642-74734-2Series ISSN 0177-8757 作者: 極大的痛苦 時(shí)間: 2025-3-24 00:14
Erlebnisinszenierung in den sozialen Medien,n the subject of numerous investigations especially during the last decade. This review is an attempt to summarize the present knowledge about synthesis, distribution and possible functions of 5-methylcytosine especially in eukaryotic genomes.作者: 發(fā)牢騷 時(shí)間: 2025-3-24 05:14
Einleitung und Problemstellung,e stereochemical and physicochemical characterization of MA elucidated further the complex metabolic behavior of oxazaphosphorine cytostatics and confirmed imino-CP as a transient primary intermediate.作者: 極大的痛苦 時(shí)間: 2025-3-24 06:37
,Mafosfamide — A Derivative of 4-Hydroxycyclophosphamide,e stereochemical and physicochemical characterization of MA elucidated further the complex metabolic behavior of oxazaphosphorine cytostatics and confirmed imino-CP as a transient primary intermediate.作者: 腫塊 時(shí)間: 2025-3-24 14:27
,Calcitonins — Physiological and Pharmacological Aspects,extend its therapeutic usefulness. The need to administer calcitonin by injection has limited its clinical application, but the recent introduction of an intranasal spray should improve patient acceptability.作者: 調(diào)味品 時(shí)間: 2025-3-24 17:26
Versuchsaufbau und Betriebsdaten,extend its therapeutic usefulness. The need to administer calcitonin by injection has limited its clinical application, but the recent introduction of an intranasal spray should improve patient acceptability.作者: adjacent 時(shí)間: 2025-3-24 20:39
6樓作者: 有幫助 時(shí)間: 2025-3-25 01:15
6樓作者: CAMP 時(shí)間: 2025-3-25 05:31
6樓作者: 濕潤(rùn) 時(shí)間: 2025-3-25 10:53
7樓作者: 滋養(yǎng) 時(shí)間: 2025-3-25 12:35
7樓作者: obstruct 時(shí)間: 2025-3-25 18:46
7樓作者: chronicle 時(shí)間: 2025-3-25 20:23
7樓作者: 下級(jí) 時(shí)間: 2025-3-26 02:12
8樓作者: 分開如此和諧 時(shí)間: 2025-3-26 07:34
8樓作者: Conspiracy 時(shí)間: 2025-3-26 11:31
8樓作者: 綁架 時(shí)間: 2025-3-26 14:13
9樓作者: 別名 時(shí)間: 2025-3-26 19:26
9樓作者: Stricture 時(shí)間: 2025-3-26 21:06
9樓作者: 令人發(fā)膩 時(shí)間: 2025-3-27 02:13
9樓作者: 帶來墨水 時(shí)間: 2025-3-27 07:34
10樓作者: LATER 時(shí)間: 2025-3-27 09:56
10樓作者: 極少 時(shí)間: 2025-3-27 15:48
10樓作者: BOGUS 時(shí)間: 2025-3-27 17:51
10樓
